Find clinical trials for Kidney Disease in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Kidney Disease trials near Los Angeles, CA, USA:
This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease...
Phase 3
Los Angeles, California, United States and 43 other locations
This study is researching an experimental drug called ALN-ANG3 (called "study drug"). The study is focused on participants who have diabetic kidney...
Phase 2
Los Angeles, California, United States of America and 59 other locations
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...
Phase 2
Los Angeles, California, United States and 92 other locations
The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...
Phase 2
Beverly Hills, California, United States and 62 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Los Angeles, California, United States and 330 other locations
Additionally, the study investigates the non-interventional feasibility of home measurement of serum creatinine in participants with diabetic kidney...
Phase 1
Glendale, California, United States and 5 other locations
The purpose of this study is to determine whether vonsetamig will safely decrease anti-HLA antibodies to allow for kidney transplantation.Vo...
Phase 1, Phase 2
Los Angeles, California, United States of America and 9 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Los Angeles, California, United States and 297 other locations
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compare...
Phase 3
Huntington Park, California, United States and 711 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
Los Angeles, California, United States and 89 other locations
Clinical trials
Research sites
Resources
Legal